Your Baby’s Gut Bacteria Could Counteract Genetic Risk Factors for Autism and ADHD

Before a newborn takes its first breath, molecular tags are already latched onto its DNA, silencing some genes, amplifying others. These epigenetic marks, chemical tweaks that sit on top of the genetic code without altering its sequence, act as a kind of preset volume dial for gene activity. Some of those dials, it turns out, are tuned to circuits involved in brain development. And the setting they’re left at could shape a child’s risk of neurodevelopmental conditions years later.

But here’s what nobody expected. The bacteria colonising a baby’s gut in its first year of life might be able to override some of those preset dials. That’s the central finding from a large longitudinal study of nearly a thousand families in Hong Kong, published this week in Cell Press Blue.

The research team, led by gastroenterologist Siew Chien Ng and public health researcher Hein Min Tun at the Chinese University of Hong Kong, tracked 969 families from pregnancy through to when the children turned three. They profiled DNA methylation patterns (a common form of epigenetic modification) from the umbilical cord blood of 571 infants, then paired that data with gut microbiome samples collected at 2, 6, and 12 months of age. At 36 months, the children’s neurodevelopment was assessed using a validated behavioural questionnaire screening for early signs of autism spectrum disorder and attention-deficit/hyperactivity disorder.

What emerged was something the researchers describe as a biological conversation between two systems previously studied in isolation. “We discovered a kind of conversation happening: a baby’s epigenetic setting at birth can influence their risk for neurodevelopmental disorders, but the presence of certain ‘good’ bacteria in their gut can step in and modify the risk,” says Tun.

The specifics are striking. Children who carried higher methylation levels on genes involved in neurogenesis and neurotransmitter pathways scored higher on ASD and ADHD assessments at age three. But those same children were less likely to show signs of ASD if they had acquired a bacterium called Lachnospira pectinoschiza during their first year; for ADHD, the protective species was Parabacteroides distasonis. The mediation wasn’t subtle, either. Between 8 and 17 percent of the statistical link between certain epigenetic risk markers and ADHD scores was accounted for by whether P. distasonis had colonised the infant’s gut by two months of age.

Why P. distasonis? The researchers reckon it could come down to GABA, the brain’s main inhibitory neurotransmitter. P. distasonis is a prolific GABA producer, and GABA plays a somewhat counterintuitive role in early life: it’s actually excitatory in the developing brain, not inhibitory as in adults. Reduced GABA signalling has been linked to ADHD in previous work, so a microbe that pumps out the stuff might, in a sense, help restore balance in neural circuits where epigenetic marks have thrown things off kilter.

The study also turned up a surprising finding about fathers. Caesarean delivery, as expected, disrupted the transfer of beneficial bacterial strains from mother to infant. C-section babies showed different methylation patterns across immune and neural development genes, and their gut microbiomes matured more slowly, harbouring fewer beneficial species like Bifidobacterium longum and more opportunistic pathogens. But the paternal microbiome partially compensated. By twelve months, the rate of bacterial strain sharing between fathers and C-section-born infants was comparable to mother-to-infant transmission. The researchers suggest this might reflect closer postnatal bonding between fathers and newborns in their cultural setting (though shared environment and the introduction of solid foods probably contribute too).

“The foundations for brain health are laid very early, even before birth,” says Tun. “However, we don’t want people to think this means a child’s developmental path is fixed at birth. These are complex conditions with many causes, and we’ve only uncovered a small piece of a very large puzzle.”

That caveat deserves emphasis. The study is observational, and the associations it reports, while drawn from one of the largest early-life epigenome-microbiome datasets assembled so far, could be vulnerable to false positives in some of the smaller subgroup analyses. The DNA methylation snapshot comes from a single time point (cord blood at birth), which can’t capture the dynamic, back-and-forth relationship between the epigenome and microbiome as a child grows. Laboratory experiments confirming that specific microbes causally alter neurodevelopmental trajectories are still needed.

“Certain bacteria seem to offer protection, which is exciting because it suggests there could be ways to support a child’s development through diet or probiotics in the future,” says Francis Ka Leung Chan, a gastroenterologist at the Chinese University of Hong Kong and senior author of the study. The team is continuing to follow the children in the cohort as they grow, watching for whether these early-life patterns hold up or fade with time.

The longer-term vision is perhaps the most tantalising part. If specific bacterial species can genuinely buffer against epigenetic risk for conditions like ASD and ADHD, then targeted probiotics or live biotherapeutics given in the first months of life could, conceivably, shift developmental odds for vulnerable children. We’re a long way from that sort of precision intervention. But the idea that a baby’s gut flora might talk back to its genome, nudging brain development in a healthier direction, is the kind of possibility that makes you want to keep watching this cohort grow up.

Source: Cell Press Blue, DOI: 10.1016/j.cpblue.2026.100009

Frequently Asked Questions

Could probiotics one day reduce the risk of autism or ADHD in babies?

It’s too early to recommend specific probiotics for this purpose, but the research points in an intriguing direction. Two bacterial species, Lachnospira pectinoschiza and Parabacteroides distasonis, appeared to dampen the effects of epigenetic risk factors for ASD and ADHD respectively. The researchers’ stated goal is to develop safe, non-intrusive interventions like targeted probiotics, though laboratory experiments confirming a causal link are still needed before any clinical application.

How does a C-section affect a baby’s gut bacteria and brain development risk?

Babies born by caesarean section in this study showed altered DNA methylation patterns on genes involved in immune responses and neural development, and their gut microbiomes matured more slowly during the first year. They harboured fewer beneficial species and more opportunistic pathogens compared with vaginally delivered infants. However, the study found that the paternal microbiome partially compensated for disrupted maternal transmission, and C-section birth alone was not directly associated with higher ASD or ADHD scores at age three.

What role do fathers play in seeding a baby’s gut microbiome?

More than previously appreciated, according to this research. By 12 months of age, the rate of bacterial strain sharing between fathers and their infants matched that of mothers, regardless of birth mode. In C-section babies specifically, strains from the paternal microbiome were as frequent as those from the maternal microbiome, suggesting fathers serve as a meaningful backup source of beneficial bacteria during early gut colonisation.

Is a child’s risk of neurodevelopmental conditions fixed at birth?

No, and the researchers stress this point. While epigenetic patterns present at birth were associated with later neurodevelopmental scores, the acquisition of specific gut bacteria during infancy appeared to modify those risks. ASD and ADHD are complex conditions with many contributing factors, and this study captures only one piece of the broader picture. The findings suggest early life remains a dynamic window where environmental inputs, including the microbiome, can still influence developmental trajectories.